浅析医药用途的专利保护与侵权  

Analysis of the Protection and Infringement of Patent for Medical Use

作　　者：张立得 牛继梅 ZHANG Lide;NIU Jimei(SIMBA IP LAW FIRM,Tsingtao 266000,China)

机构地区：[1]山东三邦知识产权代理事务所,青岛266000

出　　处：《专利代理》2024年第3期44-51,共8页Patent Agency

摘　　要：医药用途专利所致力于保护的是药效成分所展现出来的新的适应证。在药品生产经营过程中,专利适应证的不当信息泄露会导致医药用途专利权人的利益受损。在这种情况下,采用缩减标签制度,规范医生的行医行为,并弱化国际非专利药名称,能够最大程度地避免专利适应证的不当信息泄露,不但保障了医药用途专利权人的合法权益,还能够尽可能地避免医药用途专利侵权事件的发生。The patent for medical use aims to protect the new indications exhibited by the active ingredients.In the process of drug production and operation,improper disclosure of patent indications can lead to damage to the interests of patent holders for medical use.In this situation,adopting a“Skinny Label”system,regulating the medical practices of doctors and weakening International Nonproprietary Names can maximize the avoidance of inappropriate information leakage of patent indications,not only protecting the legitimate rights and interests of patent holders,but also minimizing the occurrence of medical use patent infringement incidents.

关 键 词：医药用途 侵权判定 缩减标签 行医规范 国际非专利药名称 

分 类 号：D923.42[政治法律—民商法学]